Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Host range, transmissibility and antigenicity of a pangolin coronavirus.

Autor: Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Moderna Inc., Cambridge, MA, USA., Chiba S; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Meganck RM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Martinez DR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sontake V; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., West A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Edwards CE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yount B; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lee RE; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gallant SC; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zost SJ; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Powers J; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Adams L; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kong EF; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mattocks M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tata A; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., Randell SH; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Tata PR; Department of Cell Biology, Regeneration Next Initiative, Duke University Medical Center, Durham, NC, USA., Halfmann P; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA., Crowe JE Jr; Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA., Kawaoka Y; Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA.; Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.

Publikováno v: Nature microbiology [Nat Microbiol] 2023 Oct; Vol. 8 (10), pp. 1820-1833. Date of Electronic Publication: 2023 Sep 25.

Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection.

Autor: Vila T; Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA., Kong EF; Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA., Montelongo-Jauregui D; Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA., Van Dijck P; Laboratory of Molecular Cell Biology, Institute of Botany and Microbiology, KU Leuven, Leuven-Heverlee, Belgium.; VIB-KU Leuven Center for Microbiology, Flanders, Belgium., Shetty AC; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA., McCracken C; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA., Bruno VM; Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA., Jabra-Rizk MA; Department of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.

Publikováno v: Virulence [Virulence] 2021 Dec; Vol. 12 (1), pp. 835-851.

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.

Autor: Owonikoko TK; Winship Cancer Institute of Emory University, Atlanta, Georgia. Electronic address: towonik@emory.edu., Niu H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Nackaerts K; KU Leuven, Universitaire Ziekenhuizen, Leuven, Belgium., Csoszi T; Hetenyi G Korhaz, Szolnok, Hungary., Ostoros G; Orszagos Koranyi TBC es Pulmonologiai Intezet, Budapest, Hungary., Mark Z; Tudogyogyintezet Torokbalint, Torokbalint, Hungary., Baik C; University of Washington Seattle Cancer Care Alliance, Seattle, Washington., Joy AA; University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada., Chouaid C; CHI de Créteil, Créteil, France., Jaime JC; Hospital Universitario Virgen del Rocio, Seville, Spain., Kolek V; Fakultni Nemocnice Olomouc, Olomouc, Czech Republic., Majem M; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Roubec J; Fakultni Nemocnice Ostrava, Ostrava Poruba, Czech Republic., Santos ES; Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida., Chiang AC; Yale University School of Medicine, New Haven, Connecticut., Speranza G; Université de Sherbrooke, Centre intégré de cancérologie de la Montéregie, Hôpital Charles Le Moyne, Greenfield Park, Quebec City, Canada., Belani CP; Penn State Cancer Institute, Hershey, Pennsylvania., Chiappori A; H. Lee Moffitt Cancer Center, Tampa, Florida., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida., Czebe K; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Byers L; Tudogyogyintezet Torokbalint, Törökbálint, Hungary., Bahamon B; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Li C; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Sheldon-Waniga E; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Kong EF; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Williams M; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Badola S; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Shin H; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bedford L; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ecsedy JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Bryant M; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Jones S; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Simmons J; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Leonard EJ; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Ullmann CD; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts., Spigel DR; Personal Genome Diagnostics, Baltimore, Maryland.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Feb; Vol. 15 (2), pp. 274-287. Date of Electronic Publication: 2019 Oct 23.

The oral microbiome: A Lesson in coexistence.

Autor: Sultan AS; Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, United States of America., Kong EF; Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, United States of America.; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.; Graduate Program in Life Sciences, Molecular Microbiology and Immunology Program, University of Maryland, Baltimore, Maryland, United States of America., Rizk AM; Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, United States of America., Jabra-Rizk MA; Department of Oncology and Diagnostic Sciences, Dental School, University of Maryland, Baltimore, Maryland, United States of America.; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2018 Jan 25; Vol. 14 (1), pp. e1006719. Date of Electronic Publication: 2018 Jan 25 (Print Publication: 2018).